Primary and subsequent coronary risk appraisal: New results from The Framingham Study

American Heart Journal

Volumn 139, Issue 2, 2000, Pages 272-281

  D’agostino, Ralph B ^a   Russell, Mason W ^b   Huse, Daniel M ^b   Ellison, R Curtis ^c   Silbershatz, Halit ^a   Wilson, Peter W F ^d   Hartz, Smart C ^b  

^a Boston University   (United States)

^b Medical Research International   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; COHORT STUDIES; CORONARY DISEASE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MASSACHUSETTS; MENOPAUSE; MIDDLE AGED; RISK FACTORS;

EID: 0033980090     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90236-9     Document Type: Article

References (27)

1. American Heart Association. Heart and stroke facts: 1996 statistical supplement. Dallas: American Heart Association; 1995.
2. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart-disease in Framingham. J Chron Dis 1967;20:511-24.
3. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: The Framingham Study. Am J Cardiol 1976;38:46-51.
4. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991 ;22:312-8.
5. Wilson PWF, Larson MG, Castelfi WP. Triglycerides, HDL-cholesterol and coronary artery disease: a Framingham update on their interrelations. Can J Cardiol 1994; 10(Suppl B):1-6.
6. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
7. Odell PM, Anderson KM, Kannel WB. New models for predicting cardiovascular events. J Clin Epidemiol 1994;47:583-92.
8. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heort disease: The Framingham Study. Am J Med 1977;62:707-14.
9. Abbott RD, Garrison R J, Wilson PWF, Castelli WP. Coronary heart disease risk. The importance of joint relationships among cholesterol levels in individual lipoprotein classes. Prev Med 1982;11:131-41.
10. Wilson PWF, Anderson KM. HDL cholesterol and triglycerides as risk factors for CHD. In: Descovich GC, Gaddi A, Magri DL, Lenzi S, editors. Atherosclerosis and cardiovascular disease: 7th international meeting. Dordrecht: Kluwer Academic Publishers; 1991.
11. Wilson PWF, Anderson KM, Castelli WP. The impact of triglycerides on coronary heart disease: the Framingham Study. Athero Rev 1991;22:59-63.
12. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992;70:3H-9H.
13. Castelli WP. Diet, smoking, and alcohol: influence on coronary heart disease risk. Am J Kidney Dis 1990;16:41-6.
14. Kannel WB, Wilson PW. An update on coronary risk factors. Med Clin North Am 1995;79:951-71.
15. Shurtleff D. Section 30: some characteristics related to the incidence of cardiovascular disease and death: Framingham Study 18-year follow-up. In: Kannel WB, Gordon T, editors. The Framingham Study: an epidemiological investigation of cardiovascular disease. Bethesda (MD): National Heart, Lung, and Blood Institute; 1974.
16. Cupples LA, D'Agostino RB. Some risk factors related to annual incidence of cardiac disease and death using pooled repeated biennial measures. In: Kannel WB, Wolf PA, Garrison R J, editors. The Framingham Study: an epidemiological investigation of cardiovascular disease, section 34. Bethesda (MD): National Heart, Lung, and Blood Institute; 1987.
17. Cupples LA, D'Agostino RB, Anderson KM, Kannel WB. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 1980;7:205-18.
18. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley; 1980.
19. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994;25:40-3.
20. Califf RM, Armstrong PW, Carver JR, D'Agostino RB, Strauss WE. Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 1996;27:964-1047.
21. NIH consensus development panel on triglyceride, high-density lipoprotein, and coronary heart disease. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993;269:505.10.
22. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwalo S, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328:1220-5.
23. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta.analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.
24. Assmann G, Schulte H, van Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-84.
25. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994;121:641-7.
26. Graver SA, Coupal L, Xiao-Ping H. Identifying adulls at increased risk of coronary disease. JAMA 1995;274:801-6.
27. Laurier D, Chau NP, Cazelles B, Segond P, and the PCV-METRA Group. Estimation of CHD risk in a French working population using a modified Framingham model. J Ctin Epidemiol 1994;47:1353-64.